Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies

(2020) Lihui Wang et al.   JCI Insight

What is the Current Evidence for Disease Subsets in Giant Cell Arteritis?

(2018) Kornelis S.M van der Geest et al.   Arthritis & Rheumatology

Trial of Tocilizumab in Giant-Cell Arteritis

(2017) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunodetection of NETs in Paraffin-Embedded Tissue

(2016) Volker Brinkmann et al.   Frontiers in Immunology

Neutrophil extracellular traps promote differentiation and function of fibroblasts

(2014) Akrivi Chrysanthopoulou et al.   JOURNAL OF PATHOLOGY

Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease

(2013) Konstantinos Kambas et al.   ANNALS OF THE RHEUMATIC DISEASES

Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression

(2013) Suchita Nadkarni et al.   CIRCULATION RESEARCH

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

(2012) Georgina Espígol-Frigolé et al.   ANNALS OF THE RHEUMATIC DISEASES

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ANNALS OF THE RHEUMATIC DISEASES

Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis

(2011) A. M. Lin et al.   JOURNAL OF IMMUNOLOGY

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

(2010) Gene G. Hunder et al.   ARTHRITIS AND RHEUMATISM

Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis

(2010) Ana García-Martínez et al.   ARTHRITIS CARE & RESEARCH

Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss

(2008) D Chatelain et al.   ANNALS OF THE RHEUMATIC DISEASES